Company filings profile · CIK 0001971532

Telomir Pharmaceuticals, Inc. — SEC filings & insider activity.

Real, source-linked SEC EDGAR activity for Telomir Pharmaceuticals, Inc. (TELO): 11 filings in the last 90 days vs 15 in the prior 90 (filing-velocity cooling ↓ · 0.73×). Latest material 8-K events, insider Form-4 transactions, and periodic reports — monitored for change.

✔ Verified against the public SEC EDGAR filing record as of Sep 19, 2026. Source-linked, daily-refreshed.

Material 8-K events — Telomir Pharmaceuticals, Inc.

8-K disclosures decoded by item code (the material events: agreements, results, control/management changes, impairments, restatements).

FiledEvent
Sep 17, 2026Regulation FD Disclosure; Financial Statements and Exhibits
Sep 16, 2026Item 5.07; Financial Statements and Exhibits
Sep 14, 2026Regulation FD Disclosure; Financial Statements and Exhibits
Aug 10, 2026Regulation FD Disclosure; Financial Statements and Exhibits
Jun 15, 2026Regulation FD Disclosure; Financial Statements and Exhibits
Jun 8, 2026Departure/Election of Directors or Officers; Financial Statements and Exhibits
May 20, 2026Regulation FD Disclosure; Financial Statements and Exhibits
Apr 30, 2026Other Events
Apr 24, 2026Entry into a Material Agreement; Completion of Acquisition/Disposition; Unregistered Sale of Securities; Financial Statements and Exhibits
Mar 31, 2026Other Events
Mar 31, 2026Other Events
Mar 27, 2026Departure/Election of Directors or Officers; Amendments to Bylaws/Charter; Item 5.07; Financial Statements and Exhibits
Feb 17, 2026Other Events
Feb 5, 2026Other Events
Jan 12, 2026Delisting / Listing-Rule Failure

Watch Telomir Pharmaceuticals, Inc. automatically

Add this company to a watchlist and get a webhook/email the moment it files a material 8-K, an insider Form 4, or changes its risk-factor language.

Insider transactions (Form 4 / 3 / 5)

FiledForm
Jul 27, 20264
Jul 27, 20264
Jul 27, 20264
Jun 9, 20263
May 22, 20264
May 22, 20264
May 22, 20264
May 22, 20264
Apr 24, 20264
Oct 3, 20253

Recent filings

FiledFormDetail
Sep 17, 20268-K Regulation FD Disclosure; Financial Statements and Exhibits
Sep 16, 20268-K Item 5.07; Financial Statements and Exhibits
Sep 14, 20268-K Regulation FD Disclosure; Financial Statements and Exhibits
Aug 19, 2026DEFA14A DEFA14A
Aug 14, 2026SCHEDULE 13G/A
Aug 13, 202610-Q 10-Q
Aug 10, 20268-K Regulation FD Disclosure; Financial Statements and Exhibits
Jul 28, 2026DEF 14A DEF 14A
Jul 27, 20264 4
Jul 27, 20264 4
Jul 27, 20264 4
Jun 15, 20268-K Regulation FD Disclosure; Financial Statements and Exhibits
Jun 9, 20263 3
Jun 8, 20268-K Departure/Election of Directors or Officers; Financial Statements and Exhibits
May 22, 20264 4
May 22, 20264 4
May 22, 20264 4
May 22, 20264 4
May 20, 20268-K Regulation FD Disclosure; Financial Statements and Exhibits
May 14, 202610-Q 10-Q
Apr 30, 20268-K Other Events
Apr 24, 20264 4
Apr 24, 20268-K Entry into a Material Agreement; Completion of Acquisition/Disposition; Unregistered Sale of Securities; Financial Statements and Exhibits
Mar 31, 20268-K Other Events
Mar 31, 20268-K Other Events
Mar 27, 20268-K Departure/Election of Directors or Officers; Amendments to Bylaws/Charter; Item 5.07; Financial Statements and Exhibits
Mar 17, 202610-K 10-K
Feb 19, 2026DEFM14A DEFM14A
Feb 19, 2026DEFA14A DEFA14A
Feb 17, 20268-K Other Events
Feb 12, 2026SCHEDULE 13G/A
Feb 5, 20268-K Other Events
Feb 5, 2026PRER14A PRER14A
Jan 23, 2026PRER14A PRER14A
Jan 12, 20268-K Delisting / Listing-Rule Failure
Jan 5, 20268-K Other Events
Dec 22, 20258-K Departure/Election of Directors or Officers
Dec 17, 20258-K Other Events
Nov 28, 2025PRER14A
Nov 24, 20258-K Other Events